StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)

Close on Nov 17, 2026Market cap $15.86BP/E –Yield –

Charles River Laboratories International gross margin

Gross margin is gross profit as a percentage of revenue.

Charles River Laboratories International's gross margin for the twelve months ending Dec 26, 2020 was 36.7%. For fiscal 2017 it was 84.4%, against 83.5% the year before. The highest annual figure on record is 84.4% in fiscal 2017.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2017Dec 30, 201784.4%+0.9
FY2016Dec 31, 201683.5%+2.9
FY2015Dec 26, 201580.6%+1.2
FY2014Dec 27, 201479.5%+2.9
FY2013Dec 28, 201376.6%−0.6
FY2012Dec 29, 201277.2%+0.6
FY2011Dec 31, 201176.5%−1.1
FY2010Dec 25, 201077.7%−0.5
FY2009Dec 26, 200978.2%−2.3
FY2008Dec 27, 200880.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2024Sep 28, 202434.6%−3.1
Q2 FY2024Jun 29, 202434.5%−2.2
Q1 FY2024Mar 30, 202434.1%−3.8
Q3 FY2023Sep 30, 202335.2%−3.7
Q2 FY2023Jul 1, 202337.6%+3.6
Q1 FY2023Apr 1, 202336.7%+1.0
Q4 FY2020Dec 26, 202037.9%−0.0
Q3 FY2020Sep 26, 202038.9%+2.1
Q2 FY2020Jun 27, 202034.0%−2.2
Q1 FY2020Mar 28, 202035.6%+0.6
Q4 FY2019Dec 28, 201938.0%+0.3
Q3 FY2019Sep 28, 201936.8%−0.1
Q2 FY2019Jun 29, 201936.2%−0.7
Q1 FY2019Mar 30, 201935.0%−1.7
Q4 FY2018Dec 29, 201837.6%+2.7
Q3 FY2018Sep 29, 201836.9%−1.2
Q2 FY2018Jun 30, 201836.9%−2.6
Q1 FY2018Mar 31, 201836.7%−1.7
Q4 FY2017Dec 30, 201735.0%−3.6
Q3 FY2017Sep 30, 201738.1%+1.4
Q2 FY2017Jul 1, 201739.5%–
Q1 FY2017Apr 1, 201738.4%–
Q4 FY2016Dec 31, 201638.5%–
Q3 FY2016Sep 24, 201636.7%–

More Charles River Laboratories International figures

See a number that looks wrong?